Cargando…
Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – apoptosis-regulating factors
Kidney cancer, despite the constant upward trend in the incidence of this type of cancer (about 1.5-5.9% per year), is rather rare, representing approximately 2-3% of all adult cancers. Since recently, drugs based on so-called targeted therapy play a decisive role in the treatment of patients with m...
Autores principales: | Młot, Beata, Szczylik, Cezary, Rzepecki, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687374/ https://www.ncbi.nlm.nih.gov/pubmed/23788861 http://dx.doi.org/10.5114/wo.2012.27343 |
Ejemplares similares
-
Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – hypoxia-induced factors
por: Młot, Beata, et al.
Publicado: (2012) -
Axitinib in sequential therapy in metastatic renal cell carcinoma
por: Kuchar, Agata, et al.
Publicado: (2016) -
Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
por: Porta, Camillo, et al.
Publicado: (2017) -
Insulin-like growth factor-1 signaling in renal cell carcinoma
por: Tracz, Adam F., et al.
Publicado: (2016) -
Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model
por: Chrom, Pawel, et al.
Publicado: (2018)